ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,157Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 58

$422K Total Retail Price of All Prescriptions

Rank: 16 out of 58

483 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 483 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,628 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 604 574 1 1
ATENOLOL 438 427 2 9
OMEPRAZOLE 385 370 3 4
LISINOPRIL 382 353 4 3
LEVOTHYROXINE SODIUM 323 323 5 5
TEMAZEPAM 302 278 6 44
AMLODIPINE BESYLATE 296 292 7 2
ALPRAZOLAM 294 275 8 31
HYDROCODONE-ACETAMINOPHEN 269 247 S3 9 11
METOPROLOL TARTRATE 266 253 10 6
METFORMIN HCL 246 233 11 8
HYDROCHLOROTHIAZIDE 180 167 12 10
ALENDRONATE SODIUM 177 177 13 18
FUROSEMIDE 175 166 14 7
LORAZEPAM 145 144 15 71
WARFARIN SODIUM 137 137 16 12
DONEPEZIL HCL 136 136 17 29
FLUTICASONE PROPIONATE 127 103 18 27
TRIAMTERENE-HYDROCHLOROTHIAZID 116 116 19 139
RANITIDINE HCL 114 114 20 48
PAROXETINE HCL 113 111 21 60
GLYBURIDE 110 108 R 22 52
CITALOPRAM HBR 110 103 22 28
LOVASTATIN 104 95 24 15
DOXAZOSIN MESYLATE 103 98 25 67
GABAPENTIN 99 94 26 14
SPIRONOLACTONE 98 97 27 78
TRIAMTERENE-HCTZ 98 98 27 40
MECLIZINE HCL 86 86 29 89
CLOTRIMAZOLE-BETAMETHASONE 85 83 30 106
ALLOPURINOL 81 78 31 38
VERAPAMIL ER 81 81 31 95
GLIPIZIDE 79 79 33 32
ZOLPIDEM TARTRATE 76 75 34 16
PLAVIX 74 69 35 39
PREDNISONE 74 74 35 49
CRESTOR 73 73 37 23
VIAGRA 72 71 38 96
CLOPIDOGREL 69 62 39 24
TAMSULOSIN HCL 65 65 40 37
NAMENDA 64 64 41 42
FINASTERIDE 61 61 42 84
METOPROLOL SUCCINATE 60 60 43 22
PANTOPRAZOLE SODIUM 58 58 44 46
GEMFIBROZIL 58 56 44 56
OXYBUTYNIN CHLORIDE 58 58 44 100
ENALAPRIL MALEATE 56 56 47 35
POTASSIUM CHLORIDE 55 48 48 21
CARVEDILOL 51 42 49 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.